Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.


Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Glucose-6-phosphate dehydrogenase deficiency

Other Names for this Disease
  • G6PD deficiency
  • Hemolytic anemia due to G6PD deficiency
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.


Newline Maker

How might glucose-6-phosphate dehydrogenase (G6PD) deficiency be treated?

The most important aspect of management for G6PD deficiency is to avoid agents that might trigger an attack. In cases of acute hemolytic anemia, a blood transfusion or even an exchange transfusion may be required.[1]

The G6PD Deficiency Association, which is an advocacy group that provides information and supportive resources to individuals and families affected by G6PD deficiency, provides a list of drugs and food ingredients that individuals with this condition should avoid. They also maintain a list of low risk drugs that are generally safe to take in low doses.
Last updated: 1/23/2014

  1. Ducrocq R. Glucose-6-phosphate-dehydrogenase deficiency. Orphanet. 2004; Accessed 10/11/2011.
  2. Dugdale DC, Mason JR. Glucose-6-phosphate dehydrogenase deficiency . MedlinePlus. March 2010; Accessed 10/11/2011.

Clinical Trials & Research for this Disease

  • lists trials that are studying or have studied Glucose-6-phosphate dehydrogenase deficiency. Click on the link to go to to read descriptions of these studies.